Last reviewed · How we verify

Anti-scorpion venom serum Alacramyn — Competitive Intelligence Brief

Anti-scorpion venom serum Alacramyn (Anti-scorpion venom serum Alacramyn) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antivenom serum. Area: Toxicology / Emergency Medicine.

phase 3 Antivenom serum Toxicology / Emergency Medicine Biologic Live · refreshed every 30 min

Target snapshot

Anti-scorpion venom serum Alacramyn (Anti-scorpion venom serum Alacramyn) — Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.. Alacramyn is an antivenom serum that neutralizes scorpion venom toxins through specific antibodies that bind to and inactivate venom components.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Anti-scorpion venom serum Alacramyn TARGET Anti-scorpion venom serum Alacramyn Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. phase 3 Antivenom serum

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antivenom serum class)

  1. Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anti-scorpion venom serum Alacramyn — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-scorpion-venom-serum-alacramyn. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: